Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Beam Therapeutics (BEAM) Other Non Operating Income (2019 - 2025)

Beam Therapeutics (BEAM) has disclosed Other Non Operating Income for 7 consecutive years, with $50000.0 as the latest value for Q4 2025.

  • On a quarterly basis, Other Non Operating Income rose 139.06% to $50000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $700000.0, a 69.19% decrease, with the full-year FY2025 number at $700000.0, down 69.19% from a year prior.
  • Other Non Operating Income was $50000.0 for Q4 2025 at Beam Therapeutics, up from -$2.8 million in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $35.8 million in Q3 2021 to a low of -$42.3 million in Q2 2021.
  • A 5-year average of $1.7 million and a median of $598500.0 in 2025 define the central range for Other Non Operating Income.
  • Peak YoY movement for Other Non Operating Income: surged 1225.93% in 2021, then tumbled 1278.5% in 2025.
  • Beam Therapeutics' Other Non Operating Income stood at $7.4 million in 2021, then tumbled by 59.46% to $3.0 million in 2022, then crashed by 163.33% to -$1.9 million in 2023, then soared by 93.26% to -$128000.0 in 2024, then soared by 139.06% to $50000.0 in 2025.
  • Per Business Quant, the three most recent readings for BEAM's Other Non Operating Income are $50000.0 (Q4 2025), -$2.8 million (Q3 2025), and $1.1 million (Q2 2025).